Injective (INJ) surged over 12% on Saturday, reaching $3.84, as bullish momentum returned to select altcoins. The rally was supported by a 7.29% increase in 24-hour trading volume to $147.6 million and a weekly gain of 17.51%. Analysts noted a decisive technical breakout above a key resistance level, while a mainnet upgrade and a $2 million strategic acquisition by Pineapple Financial contributed to positive sentiment.
Injective (INJ) posted one of its strongest single-day performances in recent weeks, climbing over 12% to $3.84. The move coincided with improving conditions in the broader cryptocurrency market, where traders rotated capital into high-conviction assets.
Analyst Third Eye confirmed the token decisively broke above the $3.38–$3.40 resistance zone, which has now flipped into near-term support. This technical breakout signaled renewed buyer dominance and established upside targets at $4.50, $5.00, and $5.50.
The rally reflects broader shifts as volatility stabilizes and capital flows toward fundamentally strong altcoins. Rising liquidity and improving technical signals suggest the move may be structurally supported rather than a short-term bounce.
Fundamentally, the outlook was boosted by a recently approved mainnet upgrade designed to enhance execution efficiency and network performance. Furthermore, Pineapple Financial disclosed a $2 million strategic allocation into INJ, a move analysts view as a confidence signal.
